Investments, Funding & Disinvestment

The acquisition signals Novartis’s confidence that Exl-111 can outperform this proven therapy by taking an entirely different approach.

The hospital will roll out in four phases covering technical planning, project management, commissioning, and full operational launch under Apollo’s brand.

The gathering brought together ministers, investors, industry leaders, and development partners to unlock fresh capital for the sector.

Gilead will pay USD1.68 billion upfront and commit up to USD500 million in milestone payments to secure gamgertamig (OM336), Ouro’s BCMA/CD3-targeting TCE.

The 460,000-square-foot factory will sit on a 79-acre plot within the Rowen innovation district, near Dacula, Georgia, approximately 35 miles northeast of downtown Atlanta.

This building will accommodate up to 250 researchers and provides a collaborative workspace with modular laboratories designed to support both growth and interdisciplinary exchange.

Construction is expected to be complete by the third quarter of 2027, at which point the site’s workforce is also set to double.

Wegovy HD became the fourth drug to receive FDA approval through the Commissioner’s National Priority Voucher pilot programme.

The companies are competing for a share of India’s Semaglutide market, which analysts estimate will reach USD1 billion over the next two years.